AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Structure-activity relationship of [Nphe(1)]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist
Authors: Guerrini, R Calo', G Bigoni, R Rizzi, D Regoli, D Salvadori, S
Citation: R. Guerrini et al., Structure-activity relationship of [Nphe(1)]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist, J PEPT RES, 57(3), 2001, pp. 215-222
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies
Authors: Bigoni, R Cuneo, A Milani, R Roberti, MG Bardi, A Rigolin, GM Cavazzini, F Agostini, P Castoldi, G
Citation: R. Bigoni et al., Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies, LEUK LYMPH, 40(5-6), 2001, pp. 581-590
Endogenous nociceptin signaling and stress-induced analgesia
Authors: Rizzi, A Marzola, G Bigoni, R Guerrini, R Salvadori, S Mogil, JS Regoli, D Calo, G
Citation: A. Rizzi et al., Endogenous nociceptin signaling and stress-induced analgesia, NEUROREPORT, 12(14), 2001, pp. 3009-3013
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zoneB cell lymphoma
Authors: Cuneo, A Bardi, A Wlodarska, I Selleslag, D Roberti, MG Bigoni, R Cavazzini, F De Angeli, C Tammiso, E del Senno, L Cavazzini, P Hagemeijer, A Castoldi, G
Citation: A. Cuneo et al., A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zoneB cell lymphoma, LEUKEMIA, 15(8), 2001, pp. 1262-1267
Multilineage involvement in the 5q-syndrome: a fluorescent in situ hybridization study on bone marrow smears
Authors: Bigoni, R Cuneo, A Milani, R Cavazzini, F Bardi, A Roberti, MG Agostini, P della Porta, M Specchia, G Rigolin, GM Castoldi, G
Citation: R. Bigoni et al., Multilineage involvement in the 5q-syndrome: a fluorescent in situ hybridization study on bone marrow smears, HAEMATOLOG, 86(4), 2001, pp. 375-381
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases
Authors: Cuneo, A Bigoni, R Roberti, MG Milani, R Agostini, P Cavazzini, F Minotto, C De Angeli, C Bardi, A Tammiso, E Negrini, M Cavazzini, P Castoldi, G
Citation: A. Cuneo et al., Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases, HAEMATOLOG, 86(1), 2001, pp. 64-70
Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens
Authors: Bigoni, R Calo, G Guerrini, R Strupish, JW Rowbotham, DJ Lambert, DG
Citation: R. Bigoni et al., Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens, BR J CL PH, 51(4), 2001, pp. 355-358
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues
Authors: Rizzi, D Bigoni, R Rizzi, A Jenck, F Wichmann, J Guerrini, R Regoli, D Calo, G
Citation: D. Rizzi et al., Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues, N-S ARCH PH, 363(5), 2001, pp. 551-555
Characterization of the locomotor activity-inhibiting effect of noeiceptin/orphanin FQ in mice
Authors: Rizzi, A Bigoni, R Marzola, G Guerrini, R Salvadori, S Regoli, D Calo, G
Citation: A. Rizzi et al., Characterization of the locomotor activity-inhibiting effect of noeiceptin/orphanin FQ in mice, N-S ARCH PH, 363(2), 2001, pp. 161-165
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor
Authors: Guerrini, R Calo, G Bigoni, R Rizzi, D Rizzi, A Zucchini, M Varani, K Hashiba, E Lambert, DG Toth, G Borea, PA Salvadori, S Regoli, D
Citation: R. Guerrini et al., Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor, J MED CHEM, 44(23), 2001, pp. 3956-3964
Dendritic cells in acute promyelocytic leukaemia
Authors: Rigolin, GM Della Porta, M Bigoni, R Tieghi, A Cuneo, A Castoldi, G
Citation: Gm. Rigolin et al., Dendritic cells in acute promyelocytic leukaemia, BR J HAEM, 114(4), 2001, pp. 830-833
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia
Authors: Rizzi, A Bigoni, R Marzola, G Guerrini, R Salvadori, S Regoli, D Calo, G
Citation: A. Rizzi et al., The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia, NEUROREPORT, 11(11), 2000, pp. 2369-2372
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features
Authors: Cuneo, A Bigoni, R Rigolin, GM Roberti, MG Milani, R Bardi, A Minotto, C Agostini, P De Angeli, C Narducci, MG Sabbioni, S Russo, G Negrini, M Castoldi, G
Citation: A. Cuneo et al., Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features, J CL ONCOL, 18(13), 2000, pp. 2607-2614
BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32)
Authors: De Angeli, C Gandini, D Cuneo, A Moretti, S Bigoni, R Roberti, MG Bardi, A Castoldi, GL Del Senno, L
Citation: C. De Angeli et al., BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32), HAEMATOLOG, 85(9), 2000, pp. 913-921
Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome
Authors: Bigoni, R Cuneo, A Roberti, MG Milani, R Bardi, A Cavazzini, F Minotto, C Castoldi, G
Citation: R. Bigoni et al., Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome, HAEMATOLOG, 85(5), 2000, pp. 486-491
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A
Authors: Guerrini, R Calo, G Rizzi, A Bigoni, R Rizzi, D Regoli, D Salvadori, S
Citation: R. Guerrini et al., Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A, PEPTIDES, 21(7), 2000, pp. 923-933
Nociceptin/orphanin FQ receptor ligands
Authors: Calo, G Bigoni, R Rizzi, A Guerrini, R Salvadori, S Regoli, D
Citation: G. Calo et al., Nociceptin/orphanin FQ receptor ligands, PEPTIDES, 21(7), 2000, pp. 935-947
The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties
Authors: Berger, H Bigoni, R Albrecht, E Richter, RM Krause, E Bienert, M Calo', G
Citation: H. Berger et al., The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties, PEPTIDES, 21(7), 2000, pp. 1131-1139
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist
Authors: Bigoni, R Calo', G Rizzi, A Guerrini, R De Risi, C Hashimoto, Y Hashiba, E Lambert, DG Regoli, D
Citation: R. Bigoni et al., In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist, N-S ARCH PH, 361(5), 2000, pp. 565-568
In vitro pharmacological profile of peptide III-BTD - A novel ligand for nociceptin/orphanin FQ and opioid receptors
Authors: Bigoni, R Rizzi, A Rizzi, D Becker, J Kieffer, BL Simonin, F Regoli, D Calo, G
Citation: R. Bigoni et al., In vitro pharmacological profile of peptide III-BTD - A novel ligand for nociceptin/orphanin FQ and opioid receptors, LIFE SCI, 68(2), 2000, pp. 233-239
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor
Authors: Guerrini, R Calo, G Bigoni, R Rizzi, A Varani, K Toth, G Gessi, S Hashiba, E Hashimoto, Y Lambert, DG Borea, PA Tomatis, R Salvadori, S Regoli, D
Citation: R. Guerrini et al., Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor, J MED CHEM, 43(15), 2000, pp. 2805-2813
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist
Authors: Calo', G Guerrini, R Bigoni, R Rizzi, A Marzola, G Okawa, H Bianchi, C Lambert, DG Salvadori, S Regoli, D
Citation: G. Calo' et al., Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist, BR J PHARM, 129(6), 2000, pp. 1183-1193
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21
Authors: Cuneo, A Roberti, MG Bigoni, R Minotto, C Bardi, A Milani, R Tieghi, A Campioni, D Cavazzini, F De Angeli, C Negrini, M Castoldi, G
Citation: A. Cuneo et al., Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21, BR J HAEM, 108(3), 2000, pp. 559-564
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23):MLL rearrangement, p53 mutation and multilineage involvement
Authors: Bigoni, R Cuneo, A Roberti, MG Moretti, S De Angeli, C Dabusti, M Campioni, D del Senno, L Biondi, A Chaplin, A Young, BD Castoldi, G
Citation: R. Bigoni et al., Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23):MLL rearrangement, p53 mutation and multilineage involvement, LEUKEMIA, 13(5), 1999, pp. 704-707
13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathologic features
Authors: Cuneo, A Bigoni, R Rigolin, GM Roberti, MG Bardi, A Campioni, D Minotto, C Agostini, P Milani, R Bullrich, F Negrini, M Croce, C Castoldi, G
Citation: A. Cuneo et al., 13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathologic features, HAEMATOLOG, 84(7), 1999, pp. 589-593
Risultati: 1-25 | 26-30